rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2003-6-26
|
pubmed:abstractText |
We conducted a phase II randomized study to assess the efficacy, with response as the primary endpoint, and the toxicity of gemcitabine/cisplatin (GP) and gemcitabine/carboplatin (GC) in patients with advanced non-small cell lung cancer (NSCLC).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0169-5002
|
pubmed:author |
pubmed-author:BattelliTullioT,
pubmed-author:BonsignoriMaurizioM,
pubmed-author:BuzziFrancoF,
pubmed-author:CatanzaniSergioS,
pubmed-author:De SignoribusGiorgioG,
pubmed-author:Di LulloLiberatoL,
pubmed-author:LippePaoloP,
pubmed-author:MassacesiCristianC,
pubmed-author:MattioliRodolfoR,
pubmed-author:MazzantiPaolaP,
pubmed-author:MoraleDonatellaD,
pubmed-author:PiloneAlbertaA,
pubmed-author:RocchiMarco B LMB,
pubmed-author:RossiGiorgioG,
pubmed-author:SturbaFabioF,
pubmed-author:TrivisonneRaffaeleR,
pubmed-author:TuveriGuidoG
|
pubmed:issnType |
Print
|
pubmed:volume |
41
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
81-9
|
pubmed:dateRevised |
2006-4-24
|
pubmed:meshHeading |
pubmed-meshheading:12826316-Adolescent,
pubmed-meshheading:12826316-Adult,
pubmed-meshheading:12826316-Aged,
pubmed-meshheading:12826316-Antimetabolites, Antineoplastic,
pubmed-meshheading:12826316-Antineoplastic Agents,
pubmed-meshheading:12826316-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12826316-Carboplatin,
pubmed-meshheading:12826316-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:12826316-Cisplatin,
pubmed-meshheading:12826316-Deoxycytidine,
pubmed-meshheading:12826316-Female,
pubmed-meshheading:12826316-Humans,
pubmed-meshheading:12826316-Lung Neoplasms,
pubmed-meshheading:12826316-Male,
pubmed-meshheading:12826316-Middle Aged,
pubmed-meshheading:12826316-Prognosis,
pubmed-meshheading:12826316-Prospective Studies,
pubmed-meshheading:12826316-Survival Rate,
pubmed-meshheading:12826316-Treatment Outcome
|
pubmed:year |
2003
|
pubmed:articleTitle |
Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer.
|
pubmed:affiliation |
Department of Medical Oncology, Azienda Ospedaliera Umberto I, via Conca, 60122 Torrette di Ancona, Italy. p.mazzanti@ao-umbertoprimo.marche.it
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study,
Clinical Trial, Phase II
|